Anzeige
Mehr »
Login
Montag, 24.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
KI-Wunder? Diese Aktie verachtfacht sich nach Deepseek R1-Integration!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NAKZ | ISIN: US4046091090 | Ticker-Symbol: AWT
Frankfurt
24.02.25
08:23 Uhr
28,600 Euro
-0,600
-2,05 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
HACKETT GROUP INC Chart 1 Jahr
5-Tage-Chart
HACKETT GROUP INC 5-Tage-Chart
RealtimeGeldBriefZeit
29,00029,20019:40
ACCESS Newswire
119 Leser
Artikel bewerten:
(0)

mymediset and Answerthink Forge Strategic Partnership for MedTech Supply Chain Management

Finanznachrichten News

Innovative Partnership Combines Specialized Inventory Solutions with SAP Expertise to Revolutionize Life Sciences Operations

FREIBURG, GERMANY / ACCESS Newswire / February 24, 2025 / mymediset, the industry leader in SAP-integrated solutions for medical device inventory management is pleased to announce a strategic partnership with Answerthink®, a Hackett Group company. This collaboration is set to optimize supply chain operations in the Life Sciences industry.

The alliance brings together mymediset's cutting-edge expertise in simplifying complex consignment, loaner and field inventory processes with Answerthink's renowned proficiency in SAP implementations and digital transformation. This powerful combination is poised to address critical challenges in the MedTech supply chain, offering comprehensive solutions that leverage the full potential of SAP technology.

The partnership between mymediset and Answerthink is designed to tackle key industry pain points with a holistic approach:

Seamless SAP Integration: mymediset's specialized inventory management solutions will be seamlessly integrated into Answerthink's SAP implementation and upgrade processes, providing clients with a unified, powerful platform.

Enhanced Consignment and Loaner Programs: The combined expertise will allow MedTech companies to optimize their consignment, loaner and inventory programs, significantly improving asset utilization and reducing costs.

End-to-End Visibility: Clients will benefit from comprehensive, real-time visibility across their entire supply chain, from manufacturing plants to patient care settings, enabling data-driven decision-making and proactive resource management.

Streamlined Operations: The partnership will facilitate more efficient and timely delivery of critical medical devices and products, enhancing both customer satisfaction and patient outcomes.

Tailored Solutions for Growing Enterprise Companies: Answerthink's focus on mid-market enterprises ensures that smaller to medium-sized MedTech companies can access top-tier SAP solutions and inventory management tools previously available mainly to larger corporations.

"We are extremely excited to announce our strategic partnership with Answerthink, a leading SAP platinum partner. By combining mymediset's expertise in medical device supply chain management with Answerthink's proven track record in SAP implementations, we can offer unparalleled solutions to healthcare and life sciences companies. This collaboration will enable our clients to leverage the power of SAP S/4HANA along with mymediset's specialized solutions, creating a robust platform for managing highly complex loan, consignment, and field inventory processes. Together, we aim to drive digital transformation and operational excellence in the medical device industry." - Michael Knauer, CEO & Founder, mymediset

"Answerthink is proud to partner with mymediset to provide an integrated SAP solution that streamlines the complex management of medical device inventory, ensuring critical medical products are available when and where they're needed most." - John McGrath, Managing Director, Answerthink

Driving Innovation and Efficiency in the MedTech Industry

The mymediset-Answerthink partnership is expected to yield significant benefits for MedTech companies:

Improved Operational Efficiency: Streamlined inventory management and SAP processes will lead to reduced operational costs and improved resource allocation.

Enhanced Decision-Making: Real-time data and comprehensive visibility will empower companies to make informed, strategic decisions quickly.

Accelerated Digital Transformation: The combined expertise will help companies leverage cutting-edge technologies to stay competitive in a rapidly evolving industry.

Improved Customer Satisfaction: More efficient supply chain operations will result in better service delivery and increased customer satisfaction.

Better Patient Outcomes: By optimizing the delivery of medical devices and products, the partnership will contribute to improved patient care and outcomes.

Looking Ahead

As the healthcare industry continues to evolve, the mymediset-Answerthink partnership is positioned to play a crucial role in shaping the future of MedTech supply chain management. Both companies are committed to ongoing innovation and collaboration, with plans to develop new features and capabilities that address emerging industry needs. MedTech companies interested in learning more about how this partnership can benefit their operations are encouraged to contact either mymediset or Answerthink for more information.

About mymediset

mymediset is a leading provider of SAP-integrated solutions for medical device inventory management. Specializing in simplifying complex consignment and loaner inventory processes, mymediset offers advanced tools that streamline operations, reduce costs, and improve asset utilization for healthcare organizations. By providing real-time visibility from plant to patient, mymediset empowers businesses to manage their supply chains more effectively, ultimately contributing to better patient care. https://mymediset.net/

For further information please contact
Tyra Chamness
Director, Partner Management at mymediset
tyra.chamness@mymediset.net

SOURCE: mymediset



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.